Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization. - Wikidata - wikimedia - TriplyDB

Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization.

Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization.

http://www.wikidata.org/entity/Q46762821

about

Molecular biology of lung cancer Tackling ALK in non-small cell lung cancer: the role of novel inhibitors ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it Detection of gene rearrangements in targeted clinical next-generation sequencing.Non-Small Cell Lung Carcinoma Biomarker Testing: The Pathologist's Perspective Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements.A comparison of immunohistochemical assays and FISH in detecting the ALK translocation in diagnostic histological and cytological lung tumor material.Platform comparison for evaluation of ALK protein immunohistochemical expression, genomic copy number and hotspot mutation status in neuroblastomas Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry The relevance of external quality assessment for molecular testing for ALK positive non-small cell lung cancer: results from two pilot rounds show room for optimization.Micro-cost Analysis of ALK Rearrangement Testing by FISH to Determine Eligibility for Crizotinib Therapy in NSCLC: Implications for Cost Effectiveness of Testing and Treatment Detection of ALK protein expression in lung squamous cell carcinomas by immunohistochemistry.Accurate and economical detection of ALK positive lung adenocarcinoma with semiquantitative immunohistochemical screening Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement.Molecular methods for somatic mutation testing in lung adenocarcinoma: EGFR and beyond A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma.Cutaneous inflammatory myofibroblastic tumours can be anaplastic lymphoma kinase-positive: report of the first four cases.Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer Economic Analysis of Alternative Strategies for Detection of ALK Rearrangements in Non Small Cell Lung Cancer.ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy.In situ Protein Detection for Companion Diagnostics.Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer.Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group.Efficacy of D5F3 IHC for detecting ALK gene rearrangement in NSCLC patients: a systematic review and meta-analysis.Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.ALK expression is absent in pancreatic ductal adenocarcinoma.Treatment of ALK-Rearranged Non-Small Cell Lung Cancer: Recent Progress and Future Directions.Prognostic and predictive biomarkers for targeted therapy in NSCLC: for whom the bell tolls?Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized: A Low Threshold for ALK Immunohistochemistry Is Required.Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomas.Alectinib for treatment of ALK-positive non-small-cell lung cancer.Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice.Utilization of ancillary studies in the cytologic diagnosis of respiratory lesions: The papanicolaou society of cytopathology consensus recommendations for respiratory cytology.The role of alectinib in the treatment of advanced ALK-rearranged non-small-cell lung cancer.A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer.FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival.Evaluation of immunohistochemistry using two different antibodies and procedures for primary lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangement.Simultaneous diagnostic platform of genotyping EGFR, KRAS, and ALK in 510 Korean patients with non-small-cell lung cancer highlights significantly higher ALK rearrangement rate in advanced stage.Epitope mapping of spontaneous autoantibodies to anaplastic lymphoma kinase (ALK) in non-small cell lung cancer.

P2860

Q24606677-9C2939D6-1F70-49CA-A786-CA653B4510D3 Q26740329-1FCE7D3F-9B61-4ABF-B223-59DC5B3936B3 Q28083386-C80F89D7-7585-4E4E-84BE-569C5EC163E3 Q33833183-850405B1-51A2-4EA2-908A-9655033EE056 Q33906921-11BD5023-5E66-46A8-8BA3-8A1D9D9AD324 Q33945982-BF93EC40-3E49-4F59-AD66-1C51AAF58BF4 Q34041818-44B494B8-C693-4DBC-9CA3-53E0BA610341 Q34134105-3BC249DC-6CF5-4BB4-9F77-15775FD4D00B Q34231928-AADDCF6D-1D84-4B98-A5BD-6417145C0DF1 Q34489837-23D54F6B-0307-44A5-9041-C25A3F612669 Q34662576-1DF5DBA6-D1B3-411B-861E-C26D9C3C17AE Q35005185-E94B9ABD-0D79-4AF8-AC7B-CDD7C510C816 Q35131017-8819DB76-E1BA-4423-BC18-F70E5512423E Q35256603-8CDEDC93-53AE-4782-8DAB-92820561ECD5 Q35256622-7E991C8D-B717-43D4-937B-A73EBC8F95FE Q35558293-5B10A1DC-0F0A-4C08-8614-F7DAEEE4C166 Q35671219-99263E26-E2FA-4A0B-843F-2329E26C92AE Q36096398-2933A3B8-A77B-4FAB-BF1F-C87D08BDD0D9 Q36559818-424B3FC8-B81C-4835-8C12-1F144854FD49 Q36731901-CA9E5050-3C57-4D74-A8FA-D465FA9D6884 Q36866859-12C346F9-7274-4183-8174-B84960A02E42 Q37270405-184A7FD8-5A34-4CBA-B45A-0BD072C77002 Q37630493-CB835C56-B58B-4FFA-BA7C-E33831739962 Q37631021-E5622749-F2A6-4B4A-84E5-C47824D0D779 Q37688499-B492EA59-BE45-43AF-8672-656164E3C518 Q38263354-10E2190B-AB36-4B30-9CB9-CF94639037CE Q38390927-CCA79620-8657-46A7-86F8-6BD27077844F Q38528130-4F468C58-AAA4-450D-A1DC-1B618575A806 Q38584814-8BCDC828-8DFE-4E79-B141-68DE88BD6031 Q38668044-4532715C-83B8-4043-A76C-7D731A045075 Q38794422-8430BDFF-C0E1-464F-A5B3-31AC2CD736B6 Q38805618-280FC16B-4EB2-4C1A-BC2F-930C9C70AF36 Q38816700-4A81416F-DE24-498E-A13A-C792189B3D76 Q38937135-3D68D724-834E-4C2B-8AE5-7E33ED28137A Q38981789-08FD9486-5857-40B2-8739-5E60C5E73F88 Q40374075-3D7210A1-130D-45AD-98B5-D5F8275E7C44 Q40733626-7FC4C2D5-B9A5-4855-83A2-C1462CD36F6D Q41994944-5F9D25D6-E0BF-4AC9-B106-620E3F9D2C09 Q43860596-EDC6002F-C696-4F27-B07A-6718F725789B Q44897019-08B2D8F1-19EA-4C5C-AD8E-C91B6F0563DB

P2860

Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization.

http://www.wikidata.org/entity/Q46762821

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Testing for ALK rearrangement ...... rescent in situ hybridization.

@en

Testing for ALK rearrangement ...... rescent in situ hybridization.

@nl

type

label

Testing for ALK rearrangement ...... rescent in situ hybridization.

@en

Testing for ALK rearrangement ...... rescent in situ hybridization.

@nl

prefLabel

Testing for ALK rearrangement ...... rescent in situ hybridization.

@en

Testing for ALK rearrangement ...... rescent in situ hybridization.

@nl

P1433

Q46762821-68B699EA-6225-4597-9741-A0B60DD8BF83

P1476

Q46762821-E80B17F7-235A-46CF-9D54-00E0054386B1

P2093

Q46762821-10055387-3EC6-4805-BEF8-3F20D5842091

Q46762821-2C99F939-0BD9-4DE2-85CB-E804E376DFDB

Q46762821-44B228AE-9FCA-49EC-9E1F-7C33B8282770

Q46762821-4B0333C0-AA70-4487-9CF5-B26B3D105815

Q46762821-9106EA43-9941-49B4-8083-D05F3D4A2688

Q46762821-A60E3ED6-C38D-4C3E-B25E-EEDFAF89F169

Q46762821-C87E803A-D0F7-4988-853B-69946182413F

Q46762821-D107955C-E9DE-4442-86FC-12CEA02FA398

Q46762821-DD0BCC0E-9266-4D8F-A161-EF19A90DCF01

Q46762821-E66E801E-4F04-49D1-9DA6-2DEBC4379A1D

P2860

Q46762821-061D7F7B-EB27-4E6B-855C-957041AC7895

Q46762821-097A6A1F-ED5A-4E6A-B213-A0BECC851122

Q46762821-1544F0DF-F835-4716-A112-301AC8C3F28D

Q46762821-1CE857E6-DC44-473B-91F5-2F65837A5B56

Q46762821-1D34D7B3-5190-45BA-AF3E-6AD38E305F72

Q46762821-2101B91D-0212-4F23-8F88-6E52EAE69415

Q46762821-2117D769-C535-461D-A11B-861F52733B42

Q46762821-23246060-A46F-4EC4-AB11-FF257D43DF59

Q46762821-2B26D91B-B23C-4BAA-B7A8-495632A138B4

Q46762821-2DFDFC7C-4444-4618-BD4E-F9EBF78E0724

P2888

Q46762821-9E9C3F5D-9736-431C-B27E-2455C9EB77E1

P304

Q46762821-418C16CC-FBDC-460C-AAC2-542B69A42898

P31

Q46762821-48B0B1F2-6DBC-45FA-A65D-EE7BBEE8F989

P356

Q46762821-5E0B8D12-F494-495A-9909-36CD27B118F4

P433

Q46762821-F96AA5CE-8455-4BE6-ADA7-A13F996E5DD6

P478

Q46762821-C141FD7E-83B7-4DCB-8D47-BE5B5561036E

P50

Q46762821-2BFF6E0C-3FF5-498C-95E1-DDF0FADF8F37

Q46762821-6044A14E-46F0-47B6-AD25-2B993EAE5012

Q46762821-6AB14E20-7A5A-4909-A96B-71B8E5711BEA

Q46762821-C40483F1-C940-4FE9-AE60-009BF3DC80B1

P577

Q46762821-EA20835E-2D69-4C61-B42D-8CA54AB98AA0

P5875

Q46762821-2FDD21F1-7612-44A8-944B-318B401E50F2

P698

Q46762821-D5A876AD-18F6-47EB-BA04-F3FE7B059E60

P921

Q46762821-1258A1FD-DFD0-4642-98BE-C274DDAB6D3C

Q46762821-E8DCE412-43F1-4414-8F0A-2BB30AB0453F

P356

MODPATHOL.2013.87

P1433

Modern Pathology

P1476

Testing for ALK rearrangement ...... orescent in situ hybridization

@en

P2093

Benjamin Solomon

http://www.w3.org/2001/XMLSchema#string

Brian McCaughan

http://www.w3.org/2001/XMLSchema#string

Christina I Selinger

http://www.w3.org/2001/XMLSchema#string

Maija Rj Kohonen-Corish

http://www.w3.org/2001/XMLSchema#string

Poyee Yip

http://www.w3.org/2001/XMLSchema#string

Prudence A Russell

http://www.w3.org/2001/XMLSchema#string

Sandra O'Toole

http://www.w3.org/2001/XMLSchema#string

Toni-Maree Rogers

http://www.w3.org/2001/XMLSchema#string

Wendy A Cooper

http://www.w3.org/2001/XMLSchema#string

Zoe Wainer

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of a novel human homologue of the gene coding for echinoderm microtubule-associated protein (EMAP) from the Usher syndrome type 1a locus at 14q32

EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer

Cancer statistics, 2006

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

Epidermal growth factor receptor mutations in lung cancer

P2888

modpathol.2013.87

P304

1545-1553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2013.87

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237070226

http://www.w3.org/2001/XMLSchema#string

P698

23743928

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry